Enfusion, Inc. Quarterly Cost of Revenue in USD from Q1 2021 to Q3 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate cost of goods produced and sold and services rendered during the reporting period.
-
Summary
-
Enfusion, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2021 to Q3 2024.
- Enfusion, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $16.3M, a 12.6% increase year-over-year.
- Enfusion, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $64.1M, a 15.9% increase year-over-year.
- Enfusion, Inc. annual Cost of Revenue for 2023 was $57.6M, a 22.4% increase from 2022.
- Enfusion, Inc. annual Cost of Revenue for 2022 was $47.1M, a 47.9% increase from 2021.
- Enfusion, Inc. annual Cost of Revenue for 2021 was $31.8M, a 49.1% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)